Skip to main content
Female doctor

GORE® VIABAHN® Device family

Join the next generation of care in the treatment of aortoiliac occlusive disease

Aortoiliac bifurcation (kissing stent technique) lesions

Common challenges:

  • Plaque shift
  • Embolization concerns
  • Flow dynamics
  • Tapered anatomy
  • Rupture risk

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) delivers:

Case examples

Freedom from target lesion revascularization (fTLR) in kissing stents (N = 118)

fTLR Kissing graphic

 

 

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.


Moderate to severely calcified focal or diffuse lesions

Common challenges:

  • Sufficient radial strength
  • Embolization concerns
  • Need for reintervention
  • Rupture risk

The VBX Stent Graft delivers:

Case examples

fTLR in TASC II C and D lesions (N = 77)

TASC Graphic

 

 

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.


Focal or diffuse common iliac artery lesions

Common challenges:

  • Embolization concerns
  • Conformability
  • Need for reintervention (e.g., neointimal hyperplasia)
  • Rupture risk

The VBX Stent Graft delivers:

Case examples

  • Independent stainless steel ring design for flexibility and conformability.
  • Highly flexible stent and catheter facilitates deployment.
  • ePTFE graft covers and excludes disease.

Focal or diffuse external iliac artery lesions

Common challenges:

  • Deployment accuracy
  • Tortuosity
  • Vessel movement
  • Embolization concerns

The GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* delivers:

Case examples

  • Single wire nitinol frame for flexibility, trackability and fracture resistance.
  • CBAS Heparin Surface for lasting thromboresistance.1
  • ePTFE graft covers and excludes disease.

*As used by Gore, Heparin Bioactive Surface refers to Gore’s proprietary CBAS Heparin Surface.

† Data on file 2020; W. L. Gore & Associates, Inc; Flagstaff, AZ.

  1. CBAS Heparin Surface. W. L. Gore & Associates website. Accessed February 11,2021. https://www.goremedical.com/cbas/references